Balyasny Asset Management LLC Exact Sciences Corp Call Options Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$42.43 - $70.83 $521,889 - $871,209
12,300 New
12,300 $837,000
Q1 2024

May 13, 2024
BUY
$56.27 - $73.77 $331,993 - $435,243
5,900 New
5,900 $407,000
Q4 2022

Feb 14, 2023
SELL
$30.35 - $53.15 $1.89 Million - $3.31 Million
-62,300 Reduced 44.95%
76,300 $3.78 Million
Q3 2022

Nov 14, 2022
BUY
$31.97 - $49.37 $1.06 Million - $1.63 Million
33,100 Added 31.37%
138,600 $4.5 Million
Q2 2022

Aug 15, 2022
BUY
$35.61 - $76.23 $3.76 Million - $8.04 Million
105,500 New
105,500 $4.16 Million

Others Institutions Holding EXAS

# of Institutions
674
Shares Held
163M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.1B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email